DU-176b Phase IIb clinical study (venous thromboembolism): Japan-Taiwan multicenter randomized double-blind dose-finding study using Enoxaparin as a reference in patients undergoing total hip replacement
Phase 2
- Conditions
- Patients undergoing total hip arthroplasty
- Registration Number
- JPRN-jRCT2080220798
- Lead Sponsor
- DAIICHISANKYO Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 210
Inclusion Criteria
Patients undergoing unilateral total hip arthroplasty
Patients who are 20-84 years olds
Exclusion Criteria
Subjects with risks of hemorrhage
Subjects with thromboembolic risks
Subjects who weigh less than 40 kg
Subjects who are pregnant or suspect pregnancy, or subjects who want to become pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of subjects with venous thromboembolism events
- Secondary Outcome Measures
Name Time Method Proportion of subjects with bleeding events